Article
Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients.
Rheumatology (Oxford, England) - 1 Apr 2013
Ruyssen-Witrand Adeline, Rouanet Stéphanie, Combe Bernard, Dougados Maxime, Le Loët Xavier, Sibilia Jean, Tebib Jacques, Mariette Xavier, Constantin Arnaud
Abstract excerpt
OBJECTIVE: To determine whether a functional single-nucleotide polymorphism in the B-cell activating factor (BAFF) gene correlates with the response to treatment with rituximab (RTX) in RA. METHODS: SMART is a randomized open trial (NCT01126541) assessing two strategies of re-treatment in patients responding to 1-g infusion of RTX with MTX on days 1 and 15 after failure, intolerance or contraindication to TNF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
